IQuity

IQuity is a life science technology company leveraging machine learning methods to deliver breakthrough RNA diagnostics and analytics.

IQuity is a life science technology company leveraging machine learning methods to deliver breakthrough RNA diagnostics and analytics. The company’s initial offerings include Isolate tests across neurology, gastroenterology and rheumatology that are based on proprietary algorithms capable of ruling in or ruling out specific autoimmune diseases. The accuracy of these methods at the earliest onset of symptoms exceeds 90% and offers providers the ability to shorten the diagnostic process for autoimmune disease and related conditions. Most autoimmune diseases take months to years to diagnose. IQuity’s technology, IQIsolate, analyzes RNA expression data from a blood sample to identify presence or absence of disease at the cellular level and deliver a result to providers in only 7 days. RNA expression is representative of the presence of disease in real time, whereas changes in DNA indicate potential risk of disease. Using the foundations of its RNA based analytics platform, IQuity will continue to introduce other testing focused on disease monitoring and therapeutic effectiveness as well as a stand along analytics offering leveraging the understanding of RNA biology to support clinical trials, therapeutic response and claims data based misdiagnosis identification for the healthcare system. IQuity Labs was founded in 2013 and is headquartered in Nashville, Tennessee.